Therefore, through interaction with aVb3 integrin, it can trigger metastatic activity or cell growth via activation of the FAK/AKT pathway in lung cancer or activation of the JAK/STAT3 pathway in breast cancer [46, 47]. This evidence concerns the gene AKT1 and lung carcinoma.